Steven Dubinett
Dean, David Geffen School of Medicine at UCLA, Associate Vice Chancellor for Research, UCLA · UCLA David Geffen School of Medicine/UCLA Medical Center
Credentials: · ·
History
PresentDavid Geffen School of Medicine at UCLA · UCLA David Geffen School of Medicine/UCLA Medical Center
PresentDavid Geffen School of Medicine · Charles R Drew University of Medicine and Science, College of Medicine
PresentDavid Geffen School of Medicine at UCLA · University of California-Los Angeles
- 1986–1988
- 1980–1981
University Hospital
- 1976–1980
Research
Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma
The Journal of Experimental Medicine · 2005 · 470 citations
Prostaglandin E2 induces FOXP3 gene expression and T regulatory cell function in human CD4+ T cells
The Journal of Immunology · 2005 · Last of 10 authors · 468 citations
Cancer Research · 2005 · Last of 9 authors · 414 citations
- RB
33 papers
30 papers · 1 as a fellow
29 papers
28 papers
26 papers · 6 as a fellow
- JM
24 papers
20 papers · 2 as a fellow
20 papers
Grants
- 2024–2028
Evaluation of PARP7 Dependency as a Novel Therapeutic Target for Non-Small Cell Lung Cancer
Department of Veterans Affairs · I01
Contact PI · Va Greater Los Angeles Healthcare System
- 1980–2028
UCLA Tumor Immunology Institutional Training Grant
National Cancer Institute · T32
Contact PI · $8.5M · University of California Los Angeles
- 2022–2027
The Boston University - UCLA Lung Cancer Biomarker Characterization Center
National Cancer Institute · U2C
PI · $4.5M · Boston University Medical Campus
- 2016–2027
UCLA Clinical and Translational Science Institute
National Center for Advancing Translational Sciences · UL1
Contact PI · $88.7M · University of California Los Angeles
Clinical trials
- 2010
Principal investigator · Completed
ECOG-ACRIN Cancer Research Group
- 2007–2011
FDG-PET/CT Scans in Patients With Stage IIIB or Stage IV NSCLC Undergoing Chemotherapy
Study chair · Terminated
American College of Radiology Imaging Network